Published in Hepatitis Weekly, October 8th, 2007
"All patients had been pre-treated with lamivudine: 5 had YMDD...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.